EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis

Objectives The 3 aims of the work were to identify population subgroups that can benefit the most from viscosupplementation (VS), to provide recommendations on injection techniques, and to discuss VS appropriateness in clinical situations that are commonplace in daily practice. Methods The task forc...

Descripción completa

Detalles Bibliográficos
Autores: Conrozier, Thierry, Monfort Faure, Jorge, Chevalier, Xavier, Raman, Raghu, Richette, Pascal, Diraçoglù, Demirhan, Bard, Hervé, Baron, Dominique, Jerosch, Jörg, Migliore, Alberto, Henrotin, Yves
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2018
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/42153
Acceso en línea:http://hdl.handle.net/10230/42153
http://dx.doi.org/10.1177/1947603518783455
Access Level:acceso abierto
Palabra clave:Ankle
Appropriateness
Hip
Hyaluronic acid
Intraarticular injection
Knee
Osteoarthritis
Recommendations
Trapeziometacarpal
Viscosupplementation
id ES_28544eb034dccdcc31cac726134cafbc
oai_identifier_str oai:repositori.upf.edu:10230/42153
network_acronym_str ES
network_name_str España
repository_id_str
spelling EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in OsteoarthritisConrozier, ThierryMonfort Faure, JorgeChevalier, XavierRaman, RaghuRichette, PascalDiraçoglù, DemirhanBard, HervéBaron, DominiqueJerosch, JörgMigliore, AlbertoHenrotin, YvesAnkleAppropriatenessHipHyaluronic acidIntraarticular injectionKneeOsteoarthritisRecommendationsTrapeziometacarpalViscosupplementationObjectives The 3 aims of the work were to identify population subgroups that can benefit the most from viscosupplementation (VS), to provide recommendations on injection techniques, and to discuss VS appropriateness in clinical situations that are commonplace in daily practice. Methods The task force members voted on their degree of agreement on 27 statements, 36 recommendations, and 22 clinical scenarios using a 9-point scale. The strength of agreement/appropriateness/recommendation (SOA/SOR) was classified as strong if the median agreement score was ≥8. The level of consensus (LOC) was also obtained. Results Among the assumed predictors for VS failure, obesity, radiographic severity, large synovial fluid effusion, severe patellofemoral involvement, major malalignment, and gross joint instability received a large majority of agreements. The lateral mid-patellar approach was recommended for knee injection. Imaging guidance was unanimously recommended for hip and ankle. Agreement was achieved to strictly respect the dosing regimen proven by controlled trials. There was agreement for treating with VS patients with mild to moderate knee and hip OA, with normal weight or moderate overweight, insufficiently improved by first-line therapies, or who do not wish get oral treatment or who have contraindications to pain killers. The group considered the patient's wishes as a key element in therapeutic decision making. Conclusion Based on literature data and clinical experience, the EUROVISCO group proposed a set of recommendations for optimizing the results of VS, aimed to help practitioners, especially in some cases in which the patients' specificities make the therapeutic decision difficult.SAGE Publications201920192018info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/42153http://dx.doi.org/10.1177/1947603518783455reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésConrozier T, Monfort J, Chevalier X, Raman R, Richette P, Diraçoglù D. et al. EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis. Cartilage. 2018 Jun 1:1947603518783455.© Conrozier T, Monfort J, Chevalier X, Raman R, Richette P, Diraçoglù D. et al. 2018. DOI: 10.1177/1947603518783455info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/421532026-06-12T07:21:37Z
dc.title.none.fl_str_mv EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
title EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
spellingShingle EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
Conrozier, Thierry
Ankle
Appropriateness
Hip
Hyaluronic acid
Intraarticular injection
Knee
Osteoarthritis
Recommendations
Trapeziometacarpal
Viscosupplementation
title_short EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
title_full EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
title_fullStr EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
title_full_unstemmed EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
title_sort EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis
dc.creator.none.fl_str_mv Conrozier, Thierry
Monfort Faure, Jorge
Chevalier, Xavier
Raman, Raghu
Richette, Pascal
Diraçoglù, Demirhan
Bard, Hervé
Baron, Dominique
Jerosch, Jörg
Migliore, Alberto
Henrotin, Yves
author Conrozier, Thierry
author_facet Conrozier, Thierry
Monfort Faure, Jorge
Chevalier, Xavier
Raman, Raghu
Richette, Pascal
Diraçoglù, Demirhan
Bard, Hervé
Baron, Dominique
Jerosch, Jörg
Migliore, Alberto
Henrotin, Yves
author_role author
author2 Monfort Faure, Jorge
Chevalier, Xavier
Raman, Raghu
Richette, Pascal
Diraçoglù, Demirhan
Bard, Hervé
Baron, Dominique
Jerosch, Jörg
Migliore, Alberto
Henrotin, Yves
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Ankle
Appropriateness
Hip
Hyaluronic acid
Intraarticular injection
Knee
Osteoarthritis
Recommendations
Trapeziometacarpal
Viscosupplementation
topic Ankle
Appropriateness
Hip
Hyaluronic acid
Intraarticular injection
Knee
Osteoarthritis
Recommendations
Trapeziometacarpal
Viscosupplementation
description Objectives The 3 aims of the work were to identify population subgroups that can benefit the most from viscosupplementation (VS), to provide recommendations on injection techniques, and to discuss VS appropriateness in clinical situations that are commonplace in daily practice. Methods The task force members voted on their degree of agreement on 27 statements, 36 recommendations, and 22 clinical scenarios using a 9-point scale. The strength of agreement/appropriateness/recommendation (SOA/SOR) was classified as strong if the median agreement score was ≥8. The level of consensus (LOC) was also obtained. Results Among the assumed predictors for VS failure, obesity, radiographic severity, large synovial fluid effusion, severe patellofemoral involvement, major malalignment, and gross joint instability received a large majority of agreements. The lateral mid-patellar approach was recommended for knee injection. Imaging guidance was unanimously recommended for hip and ankle. Agreement was achieved to strictly respect the dosing regimen proven by controlled trials. There was agreement for treating with VS patients with mild to moderate knee and hip OA, with normal weight or moderate overweight, insufficiently improved by first-line therapies, or who do not wish get oral treatment or who have contraindications to pain killers. The group considered the patient's wishes as a key element in therapeutic decision making. Conclusion Based on literature data and clinical experience, the EUROVISCO group proposed a set of recommendations for optimizing the results of VS, aimed to help practitioners, especially in some cases in which the patients' specificities make the therapeutic decision difficult.
publishDate 2018
dc.date.none.fl_str_mv 2018
2019
2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/42153
http://dx.doi.org/10.1177/1947603518783455
url http://hdl.handle.net/10230/42153
http://dx.doi.org/10.1177/1947603518783455
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv SAGE Publications
publisher.none.fl_str_mv SAGE Publications
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404939733696512
score 15,81155